FDA Launches Real Time Adverse Event Reporting Dashboard for Cosmetic Products

Last updated: September 18, 2025
FDA Launches Real Time Adverse Event Reporting Dashboard for Cosmetic Products
Andrew Parshad
President & Founder of Quality Smart Solutions

In This Article:

FDA real time adverse event reporting dashboard for cosmetic productThe FDA adverse event reporting dashboard for cosmetic products is now live, offering businesses and consumers real time access to safety data. This launch marks an important milestone under the Modernization of Cosmetics Regulation Act (MoCRA), giving more transparency into how adverse events are tracked and reported. 

For companies in the cosmetics sector, this dashboard is more than just a database. It’s a signal that the FDA is raising the bar on accountability. Understanding how it works, what data is included, and how it impacts your compliance obligations will help you stay ahead of regulatory requirements. 

Why the FDA Launched the Dashboard 

Cosmetic safety has always been a priority for regulators, but until now adverse event reporting was limited and difficult to access. The new dashboard brings transparency by publishing reports in near real time.  

According to the FDA’s press announcement, the tool is designed to improve public access to cosmetic safety data, help businesses monitor trends and potential risks, and increase accountability under MoCRA reporting rules. 

This level of visibility is unprecedented in the U.S. cosmetics industry and will likely influence both manufacturers and importers. 

What the Dashboard Includes 

The FDA dashboard provides information on adverse event reports submitted by manufacturers, distributors, healthcare providers, and consumers. Data points include: 

  • The product name and category 
  • Description of the adverse event 
  • Date and source of the report 

It’s important to note that these reports don’t automatically prove a product is unsafe, but they do highlight trends that companies should monitor closely. 

What It Means for Cosmetic Companies 

If you manufacture, import, or distribute cosmetics in the U.S., the dashboard changes how you manage compliance. Key implications include: 

  • Heightened visibility: Issues with your products can become public faster. 
  • Regulatory scrutiny: FDA investigators can track signals more effectively. 
  • Reputation risk: Consumers and competitors also have access to this data. 

With this new level of transparency, proactive compliance becomes essential. Ensuring your labels, formulations, and reporting processes meet FDA standards is no longer optional; it’s a business necessity. 

How to Stay Compliant Under MoCRA 

The dashboard is only one piece of the broader MoCRA framework. Companies are required to submit serious adverse event reports within 15 business days, maintain detailed safety substantiation for all products, and ensure facility and product registration with the FDA. 

Non compliance can lead to enforcement actions and reputational damage. Working with a regulatory partner like Quality Smart Solutions can help you manage these requirements with clarity and confidence.  

Key Takeaways from the FDA Adverse Event Reporting Dashboard 

  • The FDA adverse event reporting dashboard increases transparency in cosmetics safety. 
  • Businesses must monitor the dashboard to stay aware of potential issues. 
  • Reports don’t confirm a product is unsafe but highlight potential risks. 
  • MoCRA requires timely reporting, registration, and substantiation. 
  • Proactive compliance reduces risk and protects your brand reputation. 

FAQs

Do adverse event reports mean my product is unsafe?

No. Reports are submitted by many sources and don’t automatically confirm a product defect. They signal potential risks that should be evaluated. 

Ignoring it can create risks. Even small businesses are subject to FDA requirements, and the dashboard makes compliance visible to everyone. 

Compliance can feel complex, but with expert guidance, you can implement the right processes to meet requirements without slowing your business growth.

Next Steps

The launch of the FDA adverse event reporting dashboard is a clear sign that regulators are prioritizing transparency and consumer safety. For businesses, it means compliance cannot be an afterthought. By staying informed and implementing the right processes, you can reduce risks and build trust with your customers. 

At Quality Smart Solutions, we help cosmetic companies navigate FDA regulations, manage MoCRA reporting, and maintain full compliance. Contact us today to learn how we can support your compliance strategy. 

0/5 (0 Reviews)
Picture of Andrew Parshad
Andrew Parshad
Andrew Parshad is President, CEO and founder of Quality Smart Solutions, a North American compliance solutions provider offering regulatory and quality assurance services to comply with FDA & Health Canada brands and ingredients regulations in the categories of dietary supplements, foods, cosmetics, OTC drugs and medical devices. Andrew started Quality Smart Solutions in 2007. Since that time he and his firm has served thousands of clients worldwide . Andrew's affiliate company, Quality IMPORT Solutions that offers import agent services into the Canadian market as a government licensed importer for foods, dietary supplements and medical devices.
Follow the expert:
Related Articles
We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.